Video Experimental Relacionado
Updated: Sep 10, 2025
10:22
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
3.6K
El papel mediador de los basófilos en el vínculo entre el triacilglicerol y el asma: un estudio de aleatorización
Xinhang Hu1,2, Muyun Peng1,2, Zhi Yang1,2
1Department of Thoracic Surgery, Second Xiangya Hospital, Central South University, No.139, Renmin Middle Road, Changsha, 410000 Hunan Province China.
3 Biotech
|August 21, 2025
Resumen
Este estudio revela que los niveles específicos de lípidos, en particular el triacilglicerol (50:2), aumentan causalmente el riesgo de asma. Las células inmunes, como los basófilos, median este vínculo, sugiriendo nuevos objetivos terapéuticos para el asma.
Área de la Ciencia:
- La genética
- Inmunología
- El metabolismo
Sus antecedentes:
- La obesidad está relacionada con un mayor riesgo de asma, pero las funciones de los lípidos séricos y las células inmunes no están claras.
- Comprender estas relaciones es crucial para desarrollar estrategias efectivas de manejo del asma.
Objetivo del estudio:
- Para investigar los efectos causales de los lípidos séricos en el asma.
- Para aclarar las funciones mediadoras de las células inmunes en la asociación lípido-asma.
Principales métodos:
- Se utilizaron datos del estudio de asociación de todo el genoma (GWAS) para 179 lípidos y 731 fenotipos de células inmunes.
- Se empleó un análisis de aleatorización mendeliana de dos pasos para evaluar las relaciones causales.
Principales resultados:
- Se identificaron 13 lípidos con efectos causales significativos en el asma (10 de riesgo, 3 de protección).
- Se descubrió que las células inmunes Basophil%CD33dimHLA-DR-CD66b median el vínculo entre el triacilglicerol (50:2) y el asma.
- El triacilglicerol (50:2) fue confirmado como un factor de riesgo de asma.
Conclusiones:
- Los niveles de triacilglicerol y las poblaciones específicas de basófilos son biomarcadores potenciales para el cribado del asma.
- Dirigirse a los triacilgliceroles y a los basófilos puede ofrecer nuevas vías terapéuticas para el asma.
Videos de Conceptos Relacionados
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
453
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
453
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:20Asthma: Pathogenesis and Management
581
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
581
01:19Antiasthma Drugs: Leukotriene Modifiers
463
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
463
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K